Characteristics | MACE (n = 483) | Non-MACE (n = 1873) | P value |
---|---|---|---|
Demographic | |||
 Age, years | 58.03 ± 9.039 | 57.95 ± 9.182 | 0.867 |
 Male, n (%) | 353 (73.1) | 1385 (73.9) | 0.701 |
Behavioral | |||
 Smoking, n (%) | 215 (44.5) | 832 (44.4) | 0.971 |
 Drinking, n (%) | 85 (17.6) | 331 (17.7) | 0.97 |
Physical | |||
 BMI, kg/m2 | 26.07 ± 3.564 | 26.07 ± 3.504 | 0.985 |
 SBP, mmHg | 129.64 ± 14.982 | 130.5 ± 16.485 | 0.27 |
 DBP, mmHg | 77.67 ± 9.913 | 77.8 ± 10.614 | 0.81 |
Medical history, n (%) | |||
 Hypertension | 299 (61.9) | 1208 (64.5) | 0.29 |
 Hyperlipidemia | 209 (43.3) | 812 (43.4) | 0.974 |
 History of MI | 50 (10.4) | 201 (10.7) | 0.81 |
 History of stroke | 29 (6.0) | 144 (7.7) | 0.206 |
 Family history of CAD | 62 (12.8) | 260 (13.9) | 0.551 |
 Previous PCI | 79 (16.4) | 317 (16.9) | 0.766 |
 Diagnosed DM, years | 7.82 ± 3.73 | 6.58 ± 3.942 | < 0.001 |
Clinical presentation, n (%) | |||
 Stable CAD | 52 (10.8) | 249 (13.3) | 0.138 |
 Unstable angina/NSTEMI | 352 (72.9) | 1267 (67.6) | 0.027 |
 STEMI | 79 (16.3) | 357 (19.1) | 0.172 |
Medical treatment, n (%) | |||
 Asprin | 479 (99.2) | 1862 (99.4) | 0.785 |
 Clopidogrel | 476 (98) | 1832 (97.8) | 0.305 |
 β-Blocker | 391 (81) | 1498 (80) | 0.632 |
 Statins | 473 (97.9) | 1827 (97.5) | 0.62 |
 ACEI/ARB | 275 (56.9) | 1028 (54.9) | 0.419 |
 Oral hypoglycemic drugs | 353 (72.9) | 1322 (70.6) | 0.321 |
 Insulin | 183 (37.9) | 649 (34.7) | 0.184 |
Laboratory results | |||
 TC, mmol/L | 4.25 ± 1.111 | 4.11 ± 1.091 | 0.015 |
 LDL-C, mmol/L | 2.49 ± 0.841 | 2.47 ± 0.89 | 0.643 |
 AIP | 0.3 ± 0.356 | 0.22 ± 0.292 | < 0.001 |
 HbA1c, % | 8.1 ± 1.269 | 7.4 ± 1.299 | < 0.001 |
 hs-CRP, mg/L | 4.18 ± 6.708 | 4.01 ± 6.877 | 0.614 |
 Creatinine, μmol/L | 71.98 ± 17.595 | 71.46 ± 19.905 | 0.604 |
 GFR, mL/min | 95.13 ± 20.680 | 95.79 ± 19.612 | 0.515 |
 LVEF, % | 61.44 ± 8.231 | 62.09 ± 8.15 | 0.118 |
Number of target vessels | 0.229 | ||
 One, n (%) | 206 (45.1) | 856 (45.7) |  |
 Multivessel, n (%) | 277 (57.3) | 1017 (54.3) |  |
Target vessels | |||
 LM, n (%) | 17 (3.5) | 75 (4) | 0.624 |
 LAD, n (%) | 290 (60) | 1121 (59.9) | 0.939 |
 LCX, n (%) | 720 (34.8) | 200 (41.4) | 0.233 |
 RCA, n (%) | 212 (43.9) | 782 (41.8) | 0.396 |
 SYNTAX score | 14.61 ± 6.971 | 12.48 ± 7.162 | < 0.001 |
 Minimal stent diameter, mm | 2.92 ± 0.457 | 2.92 ± 0.46 | 0.931 |
 Average stent length, mm | 22.27 ± 6.748 | 22.16 ± 6.43 | 0.749 |
Types of stent, n (%) | 0.338 | ||
 First generation DES | 225 (46.6) | 827 (44.2) |  |
 Second generation DES | 258 (53.4) | 1046 (55.8) |  |